Scientists test magic mushroom drug on aging brains to fight Alzheimer's clues
NCT ID NCT07386730
Summary
This early-stage study aims to understand how two drugs—psilocybin (from 'magic mushrooms') and dextromethorphan (a cough medicine ingredient)—affect brain activity and inflammation in older adults who feel low well-being. Researchers will enroll 80 healthy adults aged 50-85 to measure brain waves, blood markers, and brain scans before and after taking a single dose. The study will check if these drugs change brain patterns differently in people who have early biological signs of Alzheimer's disease, even though they show no memory problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANHEDONIA IN HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California San Francisco, Sandler Neuroscience Building
San Francisco, California, 94158, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.